One of the major factors after allogenic blood and/or marrow transplantation (BMT/PBSCT) is chronic graft-versus-host disease (cGVHD), which affects survival and quality of life (QOL). Aim of this descriptive study was to examine the difficulties and QOL of the patients who developed cGVHD following allogeneic BMT/PBSCT. Methods: Total of 74 patients have included from four BMT centers in Ankara, capital city of Turkey. The data collected via socio-demographic questionnaire, Long-term BMT recovery questionnaire, besides of EORTC QOL C30, specific questionnaire adapted from Bush BMT Symptom Inventory for measuring symptom severity and symptom distress related to cGVHD. Four wide-ranging tests covering 120 items were mailed and completed on average in 50 min. Results: The mean age was 34.8 years (range, 18-55) ; male (63.5%), married (72.9%), half of them CML and 35.7% AML. The mean time elapsed since transplant was 31 months (range, 4-156 months). Nineteen patients returned to work after transplantation, mean duration was 14 months (range, 3 -30 months). The most experienced symptoms interfering their daily activities related to cGVHD and BMT/PBSCT were; fatigue (73.9%), joint pain (72.6%), dental problems (63.9%), hair loss (62.0%), skin problems (58.8%), heartburn (56.3%), vision changes (53.1%), nail changes (51.4%), mouth/throat problems (50.0%), taste alterations (48.6%). Majority of them have reported fear of infection (74.3%) and diseases relapse (70.3%). Sexual dysfunctions (36.6%), dissatisfaction of their appearances (27.8%) and difficulties o f maintaining religious activities (30.1%) were also reported. Global health and QOL were reported to be good to excellent (mean: 65.8); only 5% rated both their global QOL and health status as very poor. The Long-term BMT Recovery Questionnaire provided t hat 58.1% of patients reported their current QOL was same or better than before transplantation, 22.9% of patients were reported as worse. Fifty-two patients reported financial difficulties from treatment and physical conditions. Forty-one patients reported social, physical and emotional dysfunctions. Conclusions: Nurses knowledge regarding QOL does have potential impact on the care delivered. Information gathered through research about symptoms experience and psychological, social, and spiritual problems w ill help nurses to improve symptom management and provide support for patients and families.
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Quality of life before and three months after allogeneic stem cell transplantation: experience of nurse support to improve rehabilitation A. Kisch, A. Pizunski (Lund, S) Many patients are not fully prepared for the rehabilitation period at home after allogeneic SCT, which may create feelings like loosing their foothold. There were three objectives of the study: -To give nurse support, emotional as well as practical, to allogeneic transplant patients during the rehabilitation period.
-To evaluate the given nurse support. -To investigate patients¡¦ QoL during the rehabilitation period. The patients included in the study were adults(age>18 years) and they received conventional myeloablative preparative regimens. The study is ongoing with the first patient included in June 2001. Until November 2002 we have recruited 22 patients to the study, with the goal to include 25 patients in total. For the nurse support the method used was semistructured telephone interviews, which were performed one, five and twelve weeks following discharge from the hospital. The interviews were structured according to eight different items: physical and emotional well-being, nutrition, skin and mucosa, pain, physical condition, sleep, relations to family and friends and ability to concentrate. To evaluate the nurse support patients answered a questionnaire three months post SCT describing their experience of the contacts with the nurse. FACT-BMT and FACT-Spiritual, questionnaires to measure QoL, were used in order to identify and characterise the problems patients experience post SCT. These questionnaires were administered prior to admission, at discharge and three months post discharge. The early results indicate that patients appreciated the nurse support and experienced that they were helped in their rehabilitation. Through the interviews it was also possible for patients living far from the hospital to receive support.The lowest score for global QoL was obtained at discharge and the highest score three months later. The ambition is to use the findings from this study to focus on the rehabilitation period for patients undergoing allogeneic SCT. To identify the problems and give the right support the nurses have an important role for these patients during the rehabilitation period. The nurse support will be given in the outward unit together with caregivers from a multidisciplinary team including physician, dietician, physiotherapist, psychologist and social worker.
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A psycho-educational support group for patients with chronic graft-versus-host disease
A. Ackerstein, L. Vider (Jerusalem, IL)
Chronic graft-versus-host disease (CGVHD) is a major complication of allogeneic bone marrow transplantation (BMT). CGVHD is a pleitropic syndrome involving the skin, liver, intestine and lungs. GVHD can cause major disabilities and even death. Many aspects of quality of life including feeling of anxiety, poor body image, impaired cognitive functions and sexuality are influenced by CGVHD. Family and social problems can also result. We established a psycho-educational supportive group for patients with CGVHD more than one year post BMT. The objectives were (1) to induce reciprocal support, (2) to increase knowledge and (3) to relate to different aspects of the disease. Eleven patients participated in the group. The group was lead by a nurse and a social worker.There were 6 males and 5 females, with ages ranging from 22-55 (median 43) years, the interval post BMT was 1-9 (median 3) years. Seven patients had limited CGVHD and the remaining four suffered from more extensive CGVHD.To eight of the ten planned meetings specialists such as a pain nurse, a physician and an alternative care professional etc.A portion of each meeting was interactive. Attendance of the patients ranged between 55-91% (median 72%). The feed back questionnaire revealed that the group was a meaningful experience for all participants. It gave them a different perspective on their status, a stage to share to support and gain to up date knowledge. The members of the group bonded enabling meaningful dialog and participation in joint activities. In conclusion, the benefits of a psycho-educational support group for CGVHD patients are clear, we recommend that these groups are formed relatively early in the post transplant period.
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Quality of life and psychological recovery post stem cell transplantation is gender-dependent R. Ovadia, Z. Shpitzer, D. Elad (Tel-Hashomer, IL) Previous reports have indicated that stem cells transplantation (SCT) procedure impair quality of life (QOL) and that recovering from transplant is a long process. We therefore established support groups as an integral part of our therapeutic algorithm post SCT. The support groups were based on the gender of the transplanted patients. Aim: The purpose of the current study was to assess the gender effect in the support groups. Primary end point was QOL. Method: Six males (Group A) and six females (Group B) participated in the study. The median age was 50 years (range, 45-60). Time from SCT was six months. The participants were off medications during the study period. They underwent 8 sessions of psychological intervention during an 8 week period. Every session was well designed and assessed specific themes of QOL. Health related QOL questionnaire (FACT -BMT Scale) was completed at the beginning of the first session and at the end of the last session. Results: Important gender effect was observed. In group A, the male patients were able for the first time to express feelings and get support from others . The main issues discussed were difficulties in returning to work or building a new career and their status in the family and society. The women patients (group B) dealt mostly with changes in appearance, body image, ability to love and be loved and rehabilitation of inter relationships. In group B (female) a strong correlation was observed between the psychological status and the perception of QOL. In group A (male) the correlation was mainly between the physical status and the perception of QOL. Conclusions: Support groups are very important for improving QOL post SCT and for achieving complete rehabilitation. The support group should be established taking the gender of the patients as a major and independent variable as topicS of interest, therapeutic tools and success rate are heavily dependent on this factor.
Symptom management
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Grading oral mucositis using World Health Organization and National Cancer Institute scoring systems M. Matrak, R. Sen, A. Yanik, H. Ender, E. Soydan, P. Topcuoglu, M. Ozcan, H. Akan (Ankara, TR) Mucositis is one of the most common treatment related complications of malign disorders and effects quality of life. There may be discrepancies if different scoring systems are used for evaluating the severity of mucositis. This study is designed to see if any difference exists between the two most common used scoring systems (World Health Organization (WHO) and National Cancer Institute (NCI)). The study is conducted in Ankara University Ibni Sina Hospital Stem Cell Unit and inpatient department. Two independent nurses evaluated the same patient consecutively each using different scoring systems; either WHO or NCI. 42 patients (23 men, 19 women) were enrolled to the study: the diagnosis was 23 AML, 11 ALL, 5 KML, 1 HL, 2 NHL and age range was 15-62.
Method: Special inquiry forms designed for mucositis and WHO or NCI Scoring charts were used by the nurses. Patients were selected randomly from a cohort of patients receiving chemotherapy. Results: Mean duration of mucositis were 8,3 and 8,73 days according to WHO and NCI scoring respectively (p=0,523). Four of the 8 patients with mucositis grade 3 and 4 received conditioning regimen for Stem Cell Transplantation. Mucositis less than 10 days was observed in 21 of the patients (50%) according to WHO, and in 19 (45.2%) according to NCI. Mucositis lasted for more than 10 days in 16 (38.09%) patients according to WHO and in 13 (30, 9%) according to NCI. The duration of antibiotic use increased in parallel to the duration of mucositis. The mean antibiotic days was 8 according to WHO in patients with mucositis less than 10 days and 22 days in patients with mucositis more than 10 days and 8 and 19 days respectively according to NCI (p=0,01). There was no correlation between the mucositis and smoking. In 15 patients with mucositis more than 10 days, blood cultures revealed a pathogen in 2 (13.3%) according to WHO and in 3 (20%) according to NCI. These results were 4 (14.8%) and 3 (11.1%) respectively in 27 patients with mucositis less than 10 days. There was no difference in blood culture growth when compared according to the duration of mucositis (p>0.1). Discussion: WHO and NCI Scoring systems can be used in grading the severity of mucositis with equal efficiency and there is a positive correlation between the duration of antibiotic usage and the duration of mucositis.
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Transdermal fentanyl can safely and effectively control mucositis-related pain -a single center experience in patients undergoing stem cell transplantation S. Gallo, N. Meliambro, F. Placanica, G. Placanica, L. Russo, F. Caridi, D. Pecora, F. Saffioti, A. Rossetti (Reggio Calabria, I) Nearly all patients undergoing stem cell transplantation experience pain due to mucositis. Therefore, one of the major goal in effective pain management for these patients include adequate pain relief, especially when opioid analgesia is required. Moreover, a precocious restore of liquid and semi-liquid diet could reduce the patient hospital stay. Transdermal Fentanyl (TF) is a potent opioid analgesic used in the treatment of cancer pain. The transdermal patch formulation provides the delivery of continuous analgesia for patients suffering with prolonged pain. We describe our experience on the use of TF for the prophylaxis and the treatment of pain-related mucositis in patients undergoing both autologous and allogeneic stem cell transplantation. Thirty-eight patients (23 males and 15 females) entered this study with median age of 41 years (range16-61 yrs). All patients received autologous stem cells from peripheral blood. Out of the 19 cases receiving allogeneic rescue (7 peripheral blood stem cells, 6 bone marrow harvest), 3 underwent an aploidentical and 3 an unrelated stem cell transplantation. Twenty-three patients were acute leukaemias, 8 lymphoproliferative disorders and 7 solid tumors. Patients were conditioned with melphalan-(14 cases), busulfan-(13 cases), TBI-(6 cases), fludarabine-(3 cases) and thiotepa-(2 cases) based regimens. TF was started at day +1 at the initial dose of 25 microg/h. Treatment was promptly up-titrating to 50 microg/h when patient experienced a failure in controlling pain, as defined by a visual analogue scale. All patients engrafted at median day +11 (range+7-+11d.). Severe mucositis was observed in 29 patients, with a median duration of 10 days (range5-13 d.). Median pain duration was 12 days (range7-21 d.). The median duration of TF therapy was 10 days (range 5-27 d.). Out of the
